Sana Biotechnology
SANA • NASDAQ • Stock Fundamentals
Sana Biotechnology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven D. Harr, with a market cap of $848.8M.
Market Cap$848.8M
Employees328.0
CEOSteven D. Harr
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Sana Biotechnology FAQ
Common questions about Sana Biotechnology
Sana Biotechnology (SANA) has a market capitalization of $848.8M and trades on NASDAQ.
Sana Biotechnology has approximately 328 employees.